ANI Has Four-Pillar Growth Strategy Following Novitium Deal

As Company Sees Q4 Revenue Increase On The Back Of Generics Sales

 
• By Akriti Seth
  
four pillars
ANI Pharma announces a four-pillar growth strategy along with Q4 2020 results • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business